As China’s biotech firms shift gears, can AI floor the accelerator?
Story summaryChinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next level?
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.